Orthopedic Software Market Size, Share & Trends Analysis Report By Product (EHR, Practice Management), By Mode of Delivery (Web/Cloud Based, On-Premise), By Application, By Region, And Segment Forecasts, 2024 - 2030
Orthopedic Software Market Growth & Trends
The global orthopedic software market size is expected to reach USD 607.0 million by 2030, registering a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the rising technological advancements in orthopedic surgeries and the increasing prevalence of orthopedic conditions such as arthritis, joint pain, and fractures. According to the CDC, around 78 million people aged 18 years and older are anticipated to have doctor-diagnosed arthritis by 2040. Moreover, the rising geriatric population is expected to drive the demand for efficient and cost-effective orthopedic surgical planning software from 2023 to 2030.
One of the key factors fueling market growth is the rising prevalence of orthopedic conditions like arthritis, cubital tunnel syndrome, and lower back pain. In addition, the aging population, which is more vulnerable to these diseases, is driving the market growth. For instance, according to a National Osteoporosis Foundation article, osteoporosis, a bone disease, makes bones fragile & more prone to breaking. Around 44 million Americans have inadequate bone density, and 10 million have osteoporosis, putting them at higher risk. Moreover, about 54 million Americans, or half of all people aged 50 and over, are at risk of fractures caused by accidents and trauma. Accordingly, the demand for Minimally Invasive (MI) surgeries among patients & healthcare professionals is fueling the market growth.
Integrating artificial intelligence (AI) powered technologies into existing software and launching novel AI-powered orthopedic solutions also fuels market growth. For instance, in May 2023, Smith+Nephew enhanced its digital surgery and robotics portfolio with two new products: Personalized Planning powered with AI & the RI.INSIGHTS Data Visualization Platform. The CORI surgical system now features RI.KNEE ROBOTICS v2.0, which integrates AI-powered Personalized Planning. This advancement allows surgeons to set initial implant placement during total knee procedures based on AI-guided reference values and preferences for patient-specific implant deformities.
AI-powered technologies enhance the capabilities of orthopedic software by providing advanced analytics, predictive modeling, and personalized treatment planning. These technologies enable more accurate diagnosis and surgical planning, reduce the risk of complications, and improve patient outcomes. In addition, AI can streamline administrative processes, such as scheduling and patient management, making healthcare delivery more efficient.
Moreover, various software has been developed to evaluate orthopedic implant fixation and bone segment motion. For instance, according to an article published by HospiMedica International, model-based roentgen stereophotogrammetric analysis software has been developed to evaluate the fixation of orthopedic implants and the movement of bone segments. This software was the first to use calibrated stereo X-ray pictures to determine the in vivo 3D position and/or relative motion of metal implants, marker beads, and/or bone segments.
The market players undertake several strategic initiatives to grow and sustain. For instance, In January 2024, athenahealth, Inc. announced that New England Orthopedic Surgeons (NEOS) would implement athenahealth’s athenaOne, a cloud-based integrated revenue cycle management, EHR, and patient engagement suit. Moreover, in March 2022, Allscripts Healthcare, LLC launched Expo, an EHR technology that provides a broad range of integrated solutions for practice management.
Orthopedic Software Market Report Highlights
- Based on product, the orthopedic EHR segment dominated the market in 2023 with a share of 25.43%. The growth is attributed to recent favorable changes in the orthopedic EHR industry, including new expansion activities, product launches, rising mergers, and acquisitions. For instance, the U.S. Orthopedic Alliance (USOA) and Allscripts Healthcare Solutions formed a strategic partnership in January 2021. Furthermore, the increasing digitalization rate has significantly boosted the overall demand for EHRs
- Based on the mode of delivery, the web/cloud-based segment is anticipated to dominate the market over the forecast period. It held the leading share of 86.56% in 2023, owing to the reliability and quick processing times of web/cloud-based systems. Furthermore, cloud-based solutions can simplify the process of obtaining available information remotely. This segment has expanded due to increased data storage, communication capacity, accessibility, reduced IT expenses, scalability, and other benefits
- Based on application, the orthopedic surgeries segment is anticipated to dominate the market in 2023 and hold the leading share of 59.82% in 2023. The need for data sharing and storage is expected to increase significantly in the upcoming period amid the growing number of orthopedic operations. As a result, the use of orthopedic software is anticipated to increase in medical facilities and other specialized settings
- In 2023, North America held the largest share of 43.01% in the market, driven by the availability of advanced infrastructure, high levels of digital literacy, and policies that permit the implementation of orthopedic software such as EHRs. For instance, the Federal Health IT Strategic Plan 2020-2025, which the federal government unveiled in May 2020, requires healthcare providers to use EHRs effectively, likely to boost the regional market throughout the forecast period
- The growing demand for technologically advanced orthopedic software/platforms has led to intense competition among market players. Key companies actively undertake various strategic initiatives to grow in the market. For instance, in March 2022, Allscripts Healthcare, LLC launched Expo, an EHR technology that provides a broad range of integrated solutions for practice management
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Mode of Delivery
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Mode of Delivery outlook
- 2.2.3. Application outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Orthopedic Software Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.2.3. Market opportunity analysis
- 3.3. Orthopedic Software Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- 3.3.3. COVID-19 Impact
- 3.3.4. Case Study & Insights
- Chapter 4. Orthopedic Software Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Orthopedic Software Market by Product Outlook
- 4.4. Digital Templating/ Preoperative Planning Software
- 4.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 4.5. Orthopedic EHR
- 4.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 4.6. Orthopedic Practice Management
- 4.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 4.7. Orthopedic PACS
- 4.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 4.8. Orthopedic RCM
- 4.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Chapter 5. Orthopedic Software Market: Mode of Delivery Estimates & Trend Analysis
- 5.1. Mode of Delivery Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Orthopedic Software Market by Mode of Delivery Outlook
- 5.4. Web/Cloud Based
- 5.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 5.5. On-Premise
- 5.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Chapter 6. Orthopedic Software Market: Application Estimates & Trend Analysis
- 6.1. Application Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Orthopedic Software Market by Application Outlook
- 6.4. Orthopedic Surgeries
- 6.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 6.5. Fracture Management
- 6.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 6.6. Others
- 6.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Chapter 7. Orthopedic Software Market: Regional Estimates & Trend Analysis, By Product, By Mode of Delivery, By Application
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. France Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework/ reimbursement structure
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework/ reimbursement structure
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework/ reimbursement structure
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework/ reimbursement structure
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. China Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. India Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework/ reimbursement structure
- 7.7.6.3. Competitive scenario
- 7.7.6.4. Singapore Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework/ reimbursement structure
- 7.8.1.3. Competitive scenario
- 7.8.1.4. Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework/ reimbursement structure
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Regulatory framework/ reimbursement structure
- 7.9.1.3. Competitive scenario
- 7.9.1.4. South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework/ reimbursement structure
- 7.9.2.3. Competitive scenario
- 7.9.2.4. Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework/ reimbursement structure
- 7.9.3.3. Competitive scenario
- 7.9.3.4. UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework/ reimbursement structure
- 7.9.4.3. Competitive scenario
- 7.9.4.4. Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization, Innovators
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. IBM
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Technology Type benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. CureMD Healthcare
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Technology Type benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. GreenWay Health LLC
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Technology Type benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Brainlab AG
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Technology Type benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Medstrat
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Technology Type benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Materialise
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Technology Type benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. NextGen Healthcare LLC
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Technology Type benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. DrChrono, Inc
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Technology Type benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Allscripts Healthcare, LLC
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Technology Type benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. eClinicalWorks
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Technology Type benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. athenahealth (acquired by Hellman & Friedman and Bain Capital)
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Technology Type benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. Stryker
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Technology Type benchmarking
- 8.3.15.4. Strategic initiatives
- 8.3.16. Exactech, Inc.
- 8.3.16.1. Company overview
- 8.3.16.2. Financial performance
- 8.3.16.3. Technology Type benchmarking
- 8.3.16.4. Strategic initiatives
- 8.3.17. OPIE Software
- 8.3.17.1. Company overview
- 8.3.17.2. Financial performance
- 8.3.17.3. Technology Type benchmarking
- 8.3.17.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook